Lineage Cell Therapeutics In shares owned by Bridgeway Capital Management
Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by Bridgeway Capital Management
from 13F filings
Historical chart of Bridgeway Capital Management investment in Lineage Cell Therapeutics In
Tip: Access up to 7 years of quarterly data
All positions including Lineage Cell Therapeutics In held by Bridgeway Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Lineage Cell Therapeutics In by Bridgeway Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $1.0M | 682k | 1.48 |
| 2023-09-30 | $923k | 782k | 1.18 |
| 2023-06-30 | $1.1M | 782k | 1.41 |
| 2023-03-31 | $1.2M | 782k | 1.50 |
| 2022-12-31 | $915k | 782k | 1.17 |
| 2022-09-30 | $273k | 242k | 1.13 |
| 2022-06-30 | $623k | 394k | 1.58 |
| 2022-03-31 | $23k | 15k | 1.57 |
| 2021-12-31 | $532k | 217k | 2.45 |
| 2021-09-30 | $575k | 228k | 2.52 |
| 2021-06-30 | $1.7M | 596k | 2.85 |
| 2021-03-31 | $1.5M | 643k | 2.35 |
| 2020-12-31 | $1.2M | 681k | 1.76 |
| 2020-09-30 | $547k | 585k | 0.94 |
| 2020-06-30 | $399k | 458k | 0.87 |
| 2020-03-31 | $438k | 529k | 0.83 |
| 2019-12-31 | $471k | 529k | 0.89 |
| 2019-09-30 | $519k | 529k | 0.98 |
More positions owned by Bridgeway Capital Management
View all positions for Bridgeway Capital Management